These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7082548)

  • 21. Serious bioavailability problems with a generic prolonged-release quinidine gluconate product.
    Meyer MC; Straughn AB; Lieberman P; Jacob J
    J Clin Pharmacol; 1982; 22(2-3):131-4. PubMed ID: 7068936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between quinidine plasma level and clinical effect for a new quinidine retard-formulation (author's transl)].
    Gaul G; Aldor E
    Arzneimittelforschung; 1981; 31(9):1486-8. PubMed ID: 7197961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Sep; 42(9):1482-7. PubMed ID: 7325456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA; Taggart WV
    Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new long acting quinidine preparation].
    Heulin A; Delvaux JC; Vacheron A
    Coeur Med Interne; 1975; 14(1):145-6. PubMed ID: 1091404
    [No Abstract]   [Full Text] [Related]  

  • 26. Disposition kinetics of two oral forms of quinidine.
    Mahon WA; Mayersohn M; Inaba T
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Kinidin-Duetter and quinidine sulphate in the prevention of atrial fibrillation. A comparison].
    Bjerkelund C; Orning OM
    Nord Med; 1967 Mar; 77(13):405-7. PubMed ID: 6020765
    [No Abstract]   [Full Text] [Related]  

  • 28. Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias.
    Resnekov L; Gibson D; Waich S; Muir J; McDonald L
    Br Heart J; 1971 Mar; 33(2):220-5. PubMed ID: 5572656
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary excretion kinetics of intact quinidine and 3-OH-quinidine after oral administration of a single oral dose of quinidine gluconate in the fasting and non-fasting state.
    St-Onge JM; Sirois G; Gagnon MA
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):363-72. PubMed ID: 6673973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of long-acting quinidine in maintaining sinus rhythm after electroconversion of atrial dysrhythmias.
    Resnekov L; Waich S; Gibson D; McDonald L
    Br Heart J; 1969 May; 31(3):395. PubMed ID: 5401840
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of metoclopramide on the absorption of an oral sustained-release quinidine product.
    Yuen GJ; Hansten PD; Collins J
    Clin Pharm; 1987 Sep; 6(9):722-5. PubMed ID: 3677569
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic interactions of nifedipine and quinidine.
    Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
    Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations.
    Jenzer HR; Hagemeijer F
    Eur J Cardiol; 1976 Dec; 4(4):447-51. PubMed ID: 63370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short- and long-acting oral quinidine preparations: clinical implications of pharmacokinetic differences.
    Woo E; Greenblatt DJ; Ochs HR
    Angiology; 1978 Mar; 29(3):243-50. PubMed ID: 646185
    [No Abstract]   [Full Text] [Related]  

  • 35. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF
    Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Echocardiographic study of left ventricular function during treatment with oral quinidine].
    Guadagni C; Bosi S; Coccolini S
    Minerva Cardioangiol; 1987; 35(1-2):83-5. PubMed ID: 3561814
    [No Abstract]   [Full Text] [Related]  

  • 37. Steady-state plasma concentrations of quinidine and propranolol.
    Mayersohn M; Perrier D; Fenster P; Marcus FI
    Am Heart J; 1979 May; 97(5):678-9. PubMed ID: 433743
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
    Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
    J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of a continuous fluid exchange system in the USP basket-stirrer dissolution test assembly. Part 11: Characterization of the dissolution profile of quinidine sustained-release dosage forms.
    Huynh-Ngoc T; Sirois Gérard
    J Pharm Belg; 1977; 32(1):67-75. PubMed ID: 16996
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacokinetics of quinidine following the administration of a single intravenous dose or single and repeated oral doses in human subjects].
    Leucuţa SE; Zdrenghea D; Poruţiu D; Stăncioiu N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(3):253-8. PubMed ID: 2891173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.